环拉氨酯
![]() | |
临床资料 | |
---|---|
其他名称 | BSM-906M |
ATC码 |
|
法律规范状态 | |
法律规范 |
|
识别信息 | |
| |
CAS号 | 5779-54-4 |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.024.821 |
化学信息 | |
化学式 | C21H24N2O4 |
摩尔质量 | 368.43 g·mol−1 |
3D模型(JSmol) | |
| |
|
环拉氨酯(INN:cyclarbamate)是一种含氮有机化合物,化学式C21H24N2O4,属于一种氨基甲酸酯,能作为肌肉松弛剂和镇静剂[2][3],1961年由法国公司Cassenne上市销售[4]。
参考文献
- ^ Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-16]. (原始内容存档于2023-08-03) (巴西葡萄牙语).
- ^ William Andrew Publishing. Pharmaceutical manufacturing encyclopedia. Elsevier. 2007: 1155 [26 November 2011]. ISBN 978-0-8155-1526-5.
- ^ World Health Organization. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance (PDF). 2004.
- ^ Gaultier M, Leperchey F. [Preliminary data on the use in clinical practice of cyclarbamate (N,N-diphenyl dicarbamate of 1,1-cyclopentanedimethanol]. La Presse Médicale. April 1962, 70: 863–4. PMID 13897295 (French).
|